Antibiotic News and Research RSS Feed - Antibiotic News and Research

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.
Bacterium can use cell-content sharing to repair damaged siblings

Bacterium can use cell-content sharing to repair damaged siblings

A University of Wyoming faculty member led a research team that discovered a certain type of soil bacteria can use their social behavior of outer membrane exchange (OME) to repair damaged cells and improve the fitness of the bacteria population as a whole. [More]
Existing anti-stroke drug can be effective in treating middle-ear infections

Existing anti-stroke drug can be effective in treating middle-ear infections

An existing anti-stroke drug is an effective treatment for middle-ear infections, showing the ability to suppress mucus overproduction, improve bacterial clearance and reduce hearing loss, according to researchers at Georgia State University and the University of Rochester. [More]
Second-generation antibiotic shows promise against common bacterial infections

Second-generation antibiotic shows promise against common bacterial infections

Researchers led by St. Jude Children's Research Hospital scientists have developed a second-generation antibiotic that shows early effectiveness against common bacterial infections that pose a serious health threat to children and adults. [More]
New study suggests ways to accelerate recovery from dangerous diarrheal disease

New study suggests ways to accelerate recovery from dangerous diarrheal disease

A new study delineates a sequential pattern of changes in the intestinal microbial population of patients recovering from cholera in Bangladesh, findings that may point to ways of speeding recovery from the dangerous diarrheal disease. [More]
Chancellor Angela Merkel calls for new plan to tackle Ebola outbreak at 68th World Health Assembly

Chancellor Angela Merkel calls for new plan to tackle Ebola outbreak at 68th World Health Assembly

Angela Merkel, Chancellor of the Federal Republic of Germany addressed delegates on the first morning of the Sixty-eighth World Health Assembly. "The WHO is the only international organization that has universal political legitimacy on global health issues,” she said. [More]
Lakewood-Amedex's novel class of antimicrobials prove effective at killing MDR-TB strains

Lakewood-Amedex's novel class of antimicrobials prove effective at killing MDR-TB strains

Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies conducted by Southern Research in Birmingham, Alabama, have demonstrated that its novel class of antimicrobials, named bisphosphocins, have proven effective at killing multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, the bacteria responsible for the chronic lung infection tuberculosis. [More]
Toxin pneumolysin causes progressive and fatal heart complications

Toxin pneumolysin causes progressive and fatal heart complications

Streptococcus pneumoniae is a major human pathogen and is known to be associated with increased risk of fatal heart complications including heart failure and heart attacks. [More]

Charity tackling antibiotic resistance welcomes latest O'Neill report

Antibiotic Research UK, the world’s first charity created to develop new antibiotics welcomes this latest O’Neill report and endorses whole heartedly its recommendations. [More]
Wearable diagnostic machines presented at Elsevier's 4th International Conference on Bio-Sensing Technology

Wearable diagnostic machines presented at Elsevier's 4th International Conference on Bio-Sensing Technology

Wearable E-skin that can measure heart rate and blood pressure, and paper diagnostic machines the size of a credit card that can give instant readings on blood and saliva samples are two new bio-sensing technologies presented at Elsevier's 4th International Conference on Bio-Sensing Technology in Lisbon, Portugal on 12 May 2015. [More]
TB Alliance announces start of clinical trial to treat XDR-TB

TB Alliance announces start of clinical trial to treat XDR-TB

TB Alliance and its partners announced the start of a clinical trial of a new regimen to treat extensively drug-resistant tuberculosis (XDR-TB). It is the first study to test an all-oral drug regimen, comprised of drugs with minimal pre-existing resistance, that has the potential to shorten, simplify, and improve treatment for XDR-TB. [More]
Bronchitis can cause pneumonia, says Loyola physician

Bronchitis can cause pneumonia, says Loyola physician

When a cold has lasted too long or a cough is especially bothersome, it's important to see a medical professional. [More]
UCL-led team develops new technique to find resistant TB faster

UCL-led team develops new technique to find resistant TB faster

The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks. [More]
Southern Indiana to be oasis free from Lyme disease, finds Indiana University researcher

Southern Indiana to be oasis free from Lyme disease, finds Indiana University researcher

Over nearly 15 years spent studying ticks, Indiana University's Keith Clay has found southern Indiana to be an oasis free from Lyme disease, the condition most associated with these arachnids that are the second most common parasitic disease vector on Earth. [More]
Fecal transplantation cures C. diff infection, eliminates multi-drug resistant pathogens

Fecal transplantation cures C. diff infection, eliminates multi-drug resistant pathogens

A fecal microbiota transplant (FMT) not only cured a case of Clostridium difficile (C. diff) infection in a 66 year old man; it eliminated populations of multi-drug resistant organisms both in the patient's gastrointestinal tract, and several other body sites. [More]
Scientists uncover new pharmaceutical strategy for treating melanoma

Scientists uncover new pharmaceutical strategy for treating melanoma

Scientists looking to better understand the mechanisms behind the origin and spread of melanoma tumors have uncovered a possible role for a decades-old antibacterial agent in treating these aggressive and increasingly common cancers. [More]
Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV). [More]
Lymphatic pump treatment may fight pneumonia by enhancing efficacy of antibiotics

Lymphatic pump treatment may fight pneumonia by enhancing efficacy of antibiotics

Lymphatic pump treatment (LPT) shows promise in managing pneumonia when combined with antibiotic treatment, according to a new study published in The Journal of the American Osteopathic Association. [More]
New device can turn smartphone into DNA-scanning fluorescent microscope

New device can turn smartphone into DNA-scanning fluorescent microscope

If you thought scanning one of those strange, square QR codes with your phone was somewhat advanced, hold on to your seat. Researchers at the University of California, Los Angeles have recently developed a device that can turn any smartphone into a DNA-scanning fluorescent microscope. [More]
Papers on antibiotic resistance, neglected diseases and future of the ocean to be discussed during G7 summit

Papers on antibiotic resistance, neglected diseases and future of the ocean to be discussed during G7 summit

Today the national science academies of the G7 countries handed three statements to their respective heads of government for discussion during the G7 summit at Schloss Elmau in early June 2015. The papers on antibiotic resistance, neglected and poverty-related diseases, and the future of the ocean were drawn up by the seven national academies under the aegis of the German National Academy of Sciences Leopoldina. [More]
1 in 5 nursing home residents with dementia harbor strains of drug-resistant bacteria

1 in 5 nursing home residents with dementia harbor strains of drug-resistant bacteria

A new study found one in five nursing home residents with advanced dementia harbor strains of drug-resistant bacteria and more than 10 percent of the drug-resistant bacteria are resistant to four or more antibiotic classes. The research was published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America. [More]
Advertisement
Advertisement